M N 2 Pill - blue oval, 11mm
Pill with imprint M N 2 is Blue, Oval and has been identified as Paroxetine Hydrochloride 20 mg. It is supplied by Mylan Pharmaceuticals Inc.
Paroxetine is used in the treatment of Anxiety and Stress; Anxiety; Depression; Generalized Anxiety Disorder; Hot Flashes and belongs to the drug class selective serotonin reuptake inhibitors. excluding Brisdelle: There is positive evidence of human fetal risk during pregnancy. Brisdelle: Not for use in pregnancy. Paroxetine 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M N 2
Paroxetine Hydrochloride
- Imprint
- M N 2
- Strength
- 20 mg
- Color
- Blue
- Size
- 11.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Selective serotonin reuptake inhibitors
- Pregnancy Category
- D - Positive evidence of risk - excluding Brisdelle, X - Not for use in pregnancy - Brisdelle
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
calcium phosphate dihydrate dibasic,
FD&C Blue No. 1,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-7002 | Mylan Pharmaceuticals Inc. |
| 51079-0774 (Discontinued) | UDL Laboratories Inc. |
Related images for "M N 2"
More about paroxetine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,503)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: selective serotonin reuptake inhibitors
- Breastfeeding
- En español
Patient resources
- Paroxetine drug information
- Paroxetine Controlled-Release Tablets
- Paroxetine Capsules
- Paroxetine Suspension
- Paroxetine Tablets
Other brands
Paxil, Paxil CR, Brisdelle, Pexeva
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.